The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy. Zhang F, Wang S, Yu C, Jin W, et al. BMC Cancer 2024;24:1585.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang F, Wang S, Yu C, Jin W, et al. The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy. BMC Cancer 2024;24:1585.
PMID: 39734198